Skip to main content

Zenas BioPharma, Inc. (NASDAQ: ZBIO) Investor Securities Class Action Lawsuit 04/17/2025

  • If you purchased shares of Zenas BioPharma, Inc. (NASDAQ: ZBIO), you have certain options and for certain investors are short and strict deadlines running. Deadline: June 16, 2025. NASDAQ: ZBIO investors should contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this case, please send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.

Site Members can sign up for company wide alerts

Lawsuit Overview

April 17, 2025 - An investor in shares of Zenas BioPharma, Inc. (NASDAQ: ZBIO) filed a lawsuit in the U.S. District Court for the District of Massachusetts over alleged violations of Federal Securities Laws by Zenas BioPharma, Inc. in connection with certain allegedly false and misleading statements made in connection with Zenas BioPharma’s September 2024 initial public offering (the ...



You must register (for free) or login to view the entire case.